Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment
Teva’s ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment
Teva’s ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment
December 26th, 2018 Editors Cardiology, Medicine
Teva Pharmaceutical, based in Israel, landed the first FDA approval for a digital inhaler with built-in sensors. The ProAir Digihaler (albuterol sulfate 117 mcg) Inhalation Powder is indicated for people suffering…
View On WordPress











